SCI Pharmtech, Inc.

TWSE:4119 Stock Report

Market Cap: NT$5.8b

SCI Pharmtech Dividends and Buybacks

Dividend criteria checks 1/6

SCI Pharmtech is a dividend paying company with a current yield of 3.09%.

Key information

3.1%

Dividend yield

-16.5%

Buyback Yield

Total Shareholder Yield-13.4%
Future Dividend Yieldn/a
Dividend Growth-10.0%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ratio155%

Recent dividend and buyback updates

Recent updates

Shareholders Shouldn’t Be Too Comfortable With SCI Pharmtech's (TWSE:4119) Strong Earnings

Nov 17
Shareholders Shouldn’t Be Too Comfortable With SCI Pharmtech's (TWSE:4119) Strong Earnings

We Think That There Are More Issues For SCI Pharmtech (TWSE:4119) Than Just Sluggish Earnings

Mar 27
We Think That There Are More Issues For SCI Pharmtech (TWSE:4119) Than Just Sluggish Earnings

Analysts Just Shipped A Captivating Upgrade To Their SCI Pharmtech, Inc. (TPE:4119) Estimates

Apr 07
Analysts Just Shipped A Captivating Upgrade To Their SCI Pharmtech, Inc. (TPE:4119) Estimates

There May Be Reason For Hope In SCI Pharmtech's (TPE:4119) Disappointing Earnings

Mar 30
There May Be Reason For Hope In SCI Pharmtech's (TPE:4119) Disappointing Earnings

SCI Pharmtech, Inc. (TPE:4119) Is Yielding 6.3% - But Is It A Buy?

Mar 08
SCI Pharmtech, Inc. (TPE:4119) Is Yielding 6.3% - But Is It A Buy?

SCI Pharmtech (TPE:4119) Shareholders Booked A 54% Gain In The Last Three Years

Jan 25
SCI Pharmtech (TPE:4119) Shareholders Booked A 54% Gain In The Last Three Years

Some SCI Pharmtech, Inc. (TPE:4119) Analysts Just Made A Major Cut To Next Year's Estimates

Dec 30
Some SCI Pharmtech, Inc. (TPE:4119) Analysts Just Made A Major Cut To Next Year's Estimates

Declining Stock and Solid Fundamentals: Is The Market Wrong About SCI Pharmtech, Inc. (TPE:4119)?

Dec 29
Declining Stock and Solid Fundamentals: Is The Market Wrong About SCI Pharmtech, Inc. (TPE:4119)?

Would SCI Pharmtech, Inc. (TPE:4119) Be Valuable To Income Investors?

Dec 08
Would SCI Pharmtech, Inc. (TPE:4119) Be Valuable To Income Investors?

A Look At The Intrinsic Value Of SCI Pharmtech, Inc. (TPE:4119)

Nov 17
A Look At The Intrinsic Value Of SCI Pharmtech, Inc. (TPE:4119)

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 4119's dividend payments have been volatile in the past 10 years.

Growing Dividend: 4119's dividend payments have fallen over the past 10 years.


Dividend Yield vs Market

SCI Pharmtech Dividend Yield vs Market
How does 4119 dividend yield compare to the market?
SegmentDividend Yield
Company (4119)3.1%
Market Bottom 25% (TW)1.9%
Market Top 25% (TW)5.4%
Industry Average (Pharmaceuticals)2.6%
Analyst forecast (4119) (up to 3 years)n/a

Notable Dividend: 4119's dividend (3.09%) is higher than the bottom 25% of dividend payers in the TW market (1.89%).

High Dividend: 4119's dividend (3.09%) is low compared to the top 25% of dividend payers in the TW market (5.45%).


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (155.4%), 4119's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 4119 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/03 07:13
End of Day Share Price 2026/01/02 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SCI Pharmtech, Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yu-Ying YangKGI Securities Co. Ltd.
Xiaowei HuangMasterlink Securities Corp.
Yijun ChenSinoPac Securities Investment Service